Selected research
Industry Research
Parenteral Drugs Glass Packaging Industry Research Report 2026
Market perspective
The global Parenteral Drugs Glass Packaging market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Parenteral Drugs Glass Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Parenteral Drugs Glass Packaging is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Parenteral Drugs Glass Packaging is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Parenteral Drugs Glass Packaging include Ypsomed Holding AG, Gerresheimer AG, SiO2 Medical Products, Schott AG, Ompi Stevanato Group, Becton Dickinson and Company, MeadWestvaco Corporation, Unilife Corporation Inc and West Pharmaceutical Services, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Parenteral Drugs Glass Packaging market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Parenteral Drugs Glass Packaging Market by Company
Ypsomed Holding AG
Gerresheimer AG
SiO2 Medical Products
Schott AG
Ompi Stevanato Group
Becton Dickinson and Company
MeadWestvaco Corporation
Unilife Corporation Inc
West Pharmaceutical Services
Terumo Corporation
Berry Plastics Corporation
Owens-Illinois
RPC Group
Graphic Packaging Group
Parenteral Drugs Glass Packaging Segment by Type
Polyvinyl Chloride (PVC)
Polyolefin
Parenteral Drugs Glass Packaging Segment by Application
Large Volume Parenteral (LVP)
Small Volume Parenteral (SVP)
Parenteral Drugs Glass Packaging Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Parenteral Drugs Glass Packaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Parenteral Drugs Glass Packaging and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Parenteral Drugs Glass Packaging.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Parenteral Drugs Glass Packaging manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Parenteral Drugs Glass Packaging by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Parenteral Drugs Glass Packaging in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Polyvinyl Chloride (PVC)
- Polyolefin
Applications
- Large Volume Parenteral (LVP)
- Small Volume Parenteral (SVP)
Companies covered
- Ypsomed Holding AG
- Gerresheimer AG
- SiO2 Medical Products
- Schott AG
- Ompi Stevanato Group
- Becton Dickinson and Company
- MeadWestvaco Corporation
- Unilife Corporation Inc
- West Pharmaceutical Services
- Terumo Corporation
- Berry Plastics Corporation
- Owens-Illinois
- RPC Group
- Graphic Packaging Group
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Parenteral Drugs Glass Packaging Market Size (2021-2032)
- 2.2.2 Global Parenteral Drugs Glass Packaging Sales (2021-2032)
- 2.2.3 Global Parenteral Drugs Glass Packaging Market Average Price (2021-2032)
- 2.3 Parenteral Drugs Glass Packaging by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Polyvinyl Chloride (PVC)
- 2.3.3 Polyolefin
- 2.4 Parenteral Drugs Glass Packaging by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Large Volume Parenteral (LVP)
- 2.4.3 Small Volume Parenteral (SVP)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Parenteral Drugs Glass Packaging Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Parenteral Drugs Glass Packaging Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Parenteral Drugs Glass Packaging Revenue of Manufacturers (2021-2026)
- 3.4 Global Parenteral Drugs Glass Packaging Average Price by Manufacturers (2021-2026)
- 3.5 Global Parenteral Drugs Glass Packaging Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Parenteral Drugs Glass Packaging, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Parenteral Drugs Glass Packaging, Product Type & Application
- 3.8 Global Manufacturers of Parenteral Drugs Glass Packaging, Established Date
- 3.9 Global Parenteral Drugs Glass Packaging Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Ypsomed Holding AG
- 4.1.1 Ypsomed Holding AG Company Information
- 4.1.2 Ypsomed Holding AG Business Overview
- 4.1.3 Ypsomed Holding AG Parenteral Drugs Glass Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Ypsomed Holding AG Parenteral Drugs Glass Packaging Product Portfolio
- 4.1.5 Ypsomed Holding AG Recent Developments
- 4.2 Gerresheimer AG
- 4.2.1 Gerresheimer AG Company Information
- 4.2.2 Gerresheimer AG Business Overview
- 4.2.3 Gerresheimer AG Parenteral Drugs Glass Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Gerresheimer AG Parenteral Drugs Glass Packaging Product Portfolio
- 4.2.5 Gerresheimer AG Recent Developments
- 4.3 SiO2 Medical Products
- 4.3.1 SiO2 Medical Products Company Information
- 4.3.2 SiO2 Medical Products Business Overview
- 4.3.3 SiO2 Medical Products Parenteral Drugs Glass Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 SiO2 Medical Products Parenteral Drugs Glass Packaging Product Portfolio
- 4.3.5 SiO2 Medical Products Recent Developments
- 4.4 Schott AG
- 4.4.1 Schott AG Company Information
- 4.4.2 Schott AG Business Overview
- 4.4.3 Schott AG Parenteral Drugs Glass Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Schott AG Parenteral Drugs Glass Packaging Product Portfolio
- 4.4.5 Schott AG Recent Developments
- 4.5 Ompi Stevanato Group
- 4.5.1 Ompi Stevanato Group Company Information
- 4.5.2 Ompi Stevanato Group Business Overview
- 4.5.3 Ompi Stevanato Group Parenteral Drugs Glass Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Ompi Stevanato Group Parenteral Drugs Glass Packaging Product Portfolio
- 4.5.5 Ompi Stevanato Group Recent Developments
- 4.6 Becton Dickinson and Company
- 4.6.1 Becton Dickinson and Company Company Information
- 4.6.2 Becton Dickinson and Company Business Overview
- 4.6.3 Becton Dickinson and Company Parenteral Drugs Glass Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Becton Dickinson and Company Parenteral Drugs Glass Packaging Product Portfolio
- 4.6.5 Becton Dickinson and Company Recent Developments
- 4.7 MeadWestvaco Corporation
- 4.7.1 MeadWestvaco Corporation Company Information
- 4.7.2 MeadWestvaco Corporation Business Overview
- 4.7.3 MeadWestvaco Corporation Parenteral Drugs Glass Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 MeadWestvaco Corporation Parenteral Drugs Glass Packaging Product Portfolio
- 4.7.5 MeadWestvaco Corporation Recent Developments
- 4.8 Unilife Corporation Inc
- 4.8.1 Unilife Corporation Inc Company Information
- 4.8.2 Unilife Corporation Inc Business Overview
- 4.8.3 Unilife Corporation Inc Parenteral Drugs Glass Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Unilife Corporation Inc Parenteral Drugs Glass Packaging Product Portfolio
- 4.8.5 Unilife Corporation Inc Recent Developments
- 4.9 West Pharmaceutical Services
- 4.9.1 West Pharmaceutical Services Company Information
- 4.9.2 West Pharmaceutical Services Business Overview
- 4.9.3 West Pharmaceutical Services Parenteral Drugs Glass Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 West Pharmaceutical Services Parenteral Drugs Glass Packaging Product Portfolio
- 4.9.5 West Pharmaceutical Services Recent Developments
- 4.10 Terumo Corporation
- 4.10.1 Terumo Corporation Company Information
- 4.10.2 Terumo Corporation Business Overview
- 4.10.3 Terumo Corporation Parenteral Drugs Glass Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Terumo Corporation Parenteral Drugs Glass Packaging Product Portfolio
- 4.10.5 Terumo Corporation Recent Developments
- 4.11 Berry Plastics Corporation
- 4.11.1 Berry Plastics Corporation Company Information
- 4.11.2 Berry Plastics Corporation Business Overview
- 4.11.3 Berry Plastics Corporation Parenteral Drugs Glass Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Berry Plastics Corporation Parenteral Drugs Glass Packaging Product Portfolio
- 4.11.5 Berry Plastics Corporation Recent Developments
- 4.12 Owens-Illinois
- 4.12.1 Owens-Illinois Company Information
- 4.12.2 Owens-Illinois Business Overview
- 4.12.3 Owens-Illinois Parenteral Drugs Glass Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Owens-Illinois Parenteral Drugs Glass Packaging Product Portfolio
- 4.12.5 Owens-Illinois Recent Developments
- 4.13 RPC Group
- 4.13.1 RPC Group Company Information
- 4.13.2 RPC Group Business Overview
- 4.13.3 RPC Group Parenteral Drugs Glass Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 RPC Group Parenteral Drugs Glass Packaging Product Portfolio
- 4.13.5 RPC Group Recent Developments
- 4.14 Graphic Packaging Group
- 4.14.1 Graphic Packaging Group Company Information
- 4.14.2 Graphic Packaging Group Business Overview
- 4.14.3 Graphic Packaging Group Parenteral Drugs Glass Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Graphic Packaging Group Parenteral Drugs Glass Packaging Product Portfolio
- 4.14.5 Graphic Packaging Group Recent Developments
5 Global Parenteral Drugs Glass Packaging Market Scenario by Region
- 5.1 Global Parenteral Drugs Glass Packaging Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Parenteral Drugs Glass Packaging Sales by Region: 2021-2032
- 5.2.1 Global Parenteral Drugs Glass Packaging Sales by Region: 2021-2026
- 5.2.2 Global Parenteral Drugs Glass Packaging Sales by Region: 2027-2032
- 5.3 Global Parenteral Drugs Glass Packaging Revenue by Region: 2021-2032
- 5.3.1 Global Parenteral Drugs Glass Packaging Revenue by Region: 2021-2026
- 5.3.2 Global Parenteral Drugs Glass Packaging Revenue by Region: 2027-2032
- 5.4 North America Parenteral Drugs Glass Packaging Market Facts & Figures by Country
- 5.4.1 North America Parenteral Drugs Glass Packaging Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Parenteral Drugs Glass Packaging Sales by Country (2021-2032)
- 5.4.3 North America Parenteral Drugs Glass Packaging Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Parenteral Drugs Glass Packaging Market Facts & Figures by Country
- 5.5.1 Europe Parenteral Drugs Glass Packaging Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Parenteral Drugs Glass Packaging Sales by Country (2021-2032)
- 5.5.3 Europe Parenteral Drugs Glass Packaging Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Parenteral Drugs Glass Packaging Market Facts & Figures by Country
- 5.6.1 Asia Pacific Parenteral Drugs Glass Packaging Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Parenteral Drugs Glass Packaging Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Parenteral Drugs Glass Packaging Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Parenteral Drugs Glass Packaging Market Facts & Figures by Country
- 5.7.1 South America Parenteral Drugs Glass Packaging Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Parenteral Drugs Glass Packaging Sales by Country (2021-2032)
- 5.7.3 South America Parenteral Drugs Glass Packaging Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Parenteral Drugs Glass Packaging Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Parenteral Drugs Glass Packaging Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Parenteral Drugs Glass Packaging Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Parenteral Drugs Glass Packaging Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Parenteral Drugs Glass Packaging Sales by Type (2021-2032)
- 6.1.1 Global Parenteral Drugs Glass Packaging Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Parenteral Drugs Glass Packaging Sales Market Share by Type (2021-2032)
- 6.2 Global Parenteral Drugs Glass Packaging Revenue by Type (2021-2032)
- 6.2.1 Global Parenteral Drugs Glass Packaging Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Parenteral Drugs Glass Packaging Revenue Market Share by Type (2021-2032)
- 6.3 Global Parenteral Drugs Glass Packaging Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Parenteral Drugs Glass Packaging Sales by Application (2021-2032)
- 7.1.1 Global Parenteral Drugs Glass Packaging Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Parenteral Drugs Glass Packaging Sales Market Share by Application (2021-2032)
- 7.2 Global Parenteral Drugs Glass Packaging Revenue by Application (2021-2032)
- 7.2.1 Global Parenteral Drugs Glass Packaging Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Parenteral Drugs Glass Packaging Revenue Market Share by Application (2021-2032)
- 7.3 Global Parenteral Drugs Glass Packaging Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Parenteral Drugs Glass Packaging Value Chain Analysis
- 8.1.1 Parenteral Drugs Glass Packaging Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Parenteral Drugs Glass Packaging Production Mode & Process
- 8.2 Parenteral Drugs Glass Packaging Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Parenteral Drugs Glass Packaging Distributors
- 8.2.3 Parenteral Drugs Glass Packaging Customers
9 Global Parenteral Drugs Glass Packaging Analyzing Market Dynamics
- 9.1 Parenteral Drugs Glass Packaging Industry Trends
- 9.2 Parenteral Drugs Glass Packaging Industry Drivers
- 9.3 Parenteral Drugs Glass Packaging Industry Opportunities and Challenges
- 9.4 Parenteral Drugs Glass Packaging Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst